Shukria Barakzai to Asharq Al-Awsat: I was on Taliban’s Hated List

Former Afghan Ambassador and Deputy Shukria Barakzai (Exclusive – Asharq Al-Awsat)
Former Afghan Ambassador and Deputy Shukria Barakzai (Exclusive – Asharq Al-Awsat)
TT

Shukria Barakzai to Asharq Al-Awsat: I was on Taliban’s Hated List

Former Afghan Ambassador and Deputy Shukria Barakzai (Exclusive – Asharq Al-Awsat)
Former Afghan Ambassador and Deputy Shukria Barakzai (Exclusive – Asharq Al-Awsat)

Shukria Barakzai, the former Afghan ambassador to Norway and a human rights activist, said she was on the Taliban's wanted list after the fall of Kabul in 2021, and attributed her successful escape from the Afghan capital to the assistance provided by the British.

“I was on the (Taliban’s) hated list, and they were looking for me after the fall of Kabul, in August 2021, until I was able to leave the Afghan capital thanks to the help of the British,” Shukria Barakzai, who is also ethnic Pashtun parliamentarian, told Asharq Al-Awsat in an exclusive interview.

In November 2014, Barakzai survived a suicide car bombing during the tenure of former President Ashraf Ghani, who condemned the terrorist attack.

The explosion, which took place a few meters away from the parliament headquarters in Kabul, failed to achieve its goal of killing the Afghan parliamentarian and journalist, but led to the death of three civilians and the injury of 22 others, most of whom were university students.

Answering Asharq Al-Awsat’s questions via voice messages on WhatsApp from London, Barakzai said: “It was not only the Taliban that threatened me, but also the corruption mafia and businessmen whom I exposed under the dome of parliament... They hate me, and I always knew that, but I didn’t pay much attention to their criticism.”

Commenting on the current situation in Afghanistan under the Taliban, she stated: “This group does not have any kind of definition of the type of state they pursue, the type of rights and duties that citizens enjoy, and what the (Taliban) as an actual government can offer (to the people).”

“In addition, the (Taliban) regime has not gained any kind of recognition from the international community and neighboring countries. As for the women of Afghanistan, they have been erased from (public) life, from work, education, social space and politics. Unfortunately, the dramatic change reveals to us the deep challenges facing our country,” the former diplomat told Asharq Al-Awsat.

Barakzai recounted that she was in the country when the Taliban seized power. She stayed at Kabul Airport during the evacuations in August 2021, until she was able to get out via a military plane to Brize Norton Airport in Britain.

“I was not someone who could hide his name, face, or voice. I was very familiar to the Afghan people, including members of the Taliban. It was a big challenge for me, and the (Taliban) members were chasing me. I was on their hatred list... Fortunately, the United Kingdom made a lot of efforts for me inside Afghanistan, and (eventually) I was evacuated to London with the help of the British and Americans,” she said.

Barakzai has five children, who all live in Europe. She noted that her eldest daughter was married and working in medicine, while her second daughter was a university student and the third was preparing to join the university.

She said in this regard: “Fortunately, none of my children decided to work in the political field, because they probably know what the life of a politician would be like. However, they are all women’s rights and human rights activists. They also show more concern for the environment. Therefore, they understand what it means to be a responsible citizen.”

Recalling the day when she was attacked and injured in Kabul before she left Afghanistan, Barakzai told Asharq Al-Awsat: “I remember that moment, November 16, 2014... It was in the morning, exactly at 10, and I remember how one was paying a heavy price for raising his voice against warlords and tycoons, drugs and the Taliban, that is, against all forms of extremism. This wasn’t the first attack against me, but it was a wake-up call for other women inside Afghanistan.”

She concluded: “The truth is that accepting women in a male dominated society like Afghanistan is not an easy task, but I will never give up. We will not concede, not only me, but I am talking about the women of Afghanistan. Of course, we will have more women in parliament if fair elections are held.”



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.